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Available online 26 January 2016Hepatocytes play a pivotal role in human homeostasis. They are essential in regulation of glucose and lipid levels
in blood and play a central role in metabolism of amino acids, lipids, drugs and xenobiotic-compounds. In addi-
tion, hepatocytes produce a major portion of proteins circulating in the blood. Hepatocytes were isolated from
liver tissue obtained from surgical resections. Proteins were extracted and processed using ﬁlter aided sample
preparation protocol and were analyzed by LC–MS/MS using high accuracy mass spectrometry. Proteins were
quantiﬁed by the ‘Total Protein Approach’ and ‘Proteomic Ruler’. We report a comprehensive proteomic analysis
of puriﬁed human hepatocytes and the human hepatoma cell line HepG2. The complete dataset comprises 9400
proteins and provides a comprehensive and quantitative depiction of the proteomes of hepatocytes and HepG2
cells at the protein titer and copy number dimensions. We describe basic cell organization and in detail energy
metabolism pathways and metabolite transport. We provide quantitative insights into protein synthesis and
drug and xenobiotics catabolism. Our data delineate differences between the native human hepatocytes and
HepG2 cells by providing for the ﬁrst time quantitative data at protein concentrations and copy numbers.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
Human hepatocyte
Human hepatocyte proteome
Quantitative proteomics
Metabolism
Transporter
ADME proteins
‘Proteomic Ruler’
‘Total Protein Approach’
FASP1. Introduction
The human liver is the largest internal organ of the human body
constituting 2.5% of an adult's body weight. It plays an important
role in maintaining glucose levels and regulating lipid titers in
the blood. The liver is a key organ for the metabolism of drugs and
other xenobiotic compounds. It also plays a central role in lipid and
amino acid metabolism. Many of the proteins circulating in the
blood, such as albumin constituting 55–70% of the total protein in
plasma, are produced in the liver. The liver functions as an excretory
organ for bile and cholesterol. It carries out endocrine functions by
modifying or amplifying hormone action and degrading circulating
hormones. Finally, the liver is an important storage organ for glyco-
gen, fat-soluble vitamins, and iron.
The liver is composed of several types of highly specialized cells:
hepatocytes, Kupffer, stellate, and sinusoidal endothelial cells. The
hepatocytes are the major fraction of cells representing about 80% ofoup, Department of Proteomics
hemistry, Am Klopferspitz 18,
iewski).
. This is an open access article underthe liver cell population. They are nearly cubical cells with 15 μm sides
[1] and have relatively small nuclei occupying 5–7% of the cell volume
[2]. Hepatocytes are often binucleated and their nuclei are frequently
anisokaryotic. The hepatocytes are rich in endoplasmic reticulum
and mitochondria reﬂecting their intense protein synthesis and energy
metabolism, respectively. Because of their pivotal role in human
homeostasis, hepatocytes have been subject of numerous studies
capturing their morphology and biochemistry [3]. Additionally,
hepatocytes have been raising a particular attention to pharmacologists
investigating the uptake, metabolism, excretion, and toxicity of
drugs [4]. Due to the limited availability of fresh human hepatocytes,
hepatoma cell lines, such as HepG2 cells, are frequently used as
in vitro substitutes [5,6].
Whereas classical biochemical approaches allow analysis of only
a limited number of proteins or enzymes, deep-proteome analyses
have the potential to cover thousands of proteins analyzing minute
amounts of biological material [7,8]. In this type of proteomic analysis
the measured spectral intensities of peptides of the digested proteins
can be transformed into protein concentrations and protein copies
per cell using the ‘Total Protein Approach’ [9] and the ‘Proteomic
Ruler’ computational method [10], respectively. Recently, we have ap-
plied this technology to analyze titers of drug transporters and otherthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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compounds in membrane fractions isolated from human liver and
hepatocytes [11–13]. In addition, we used our technology to establish
quantitative proteomic maps of a variety of mouse tissues including
small intestine [14], liver [15] and skeletal muscle [16]. In this study
we performed an in-depth proteomic analysis of puriﬁed human
hepatocytes and the hepatoma cell line HepG2. Our dataset encompass
9400proteins providing a comprehensive and quantitative repository of
proteins. Our data delineate the subcellular architecture and organiza-
tion of metabolic pathways and demonstrate differences between
hepatocytes and the cultured HepG2 cells. We report the ﬁrst in-depth
and quantitative analysis of the hepatocyte proteome.
2. Materials & methods
2.1. Human hepatocytes
Samples of normal human liver tissue were obtained from 7
donors undergoing surgical resections carried out at the Department
of Surgery at Uppsala University Hospital. All donors gave their
informed consent. Ethical approval was granted by the Uppsala
Regional Ethics Committee (ethical approval no 2009/028). Clinical
characteristics of the patients are given in Supplemental Table 1.
Hepatocytes were isolated by the two-step collagenase isolation pro-
cedure [17] and stored at−80 °C until subcellular fractionation and
proteomic analysis.
2.2. Cell culture
The human hepatoma cells HepG2 (ATCC HB-8065) were grown in
Eagle's Minimum Essential Medium supplemented with 10% fetal calf
serum and 1% streptomycin. The cells were harvested at 70% conﬂuence
and stored at−80 °C until proteomic analysis.
2.3. Subcellular fractionation of hepatocytes
The frozen hepatocytes were thawed on ice and suspended in
homogenization buffer composed of 0.3 M sucrose, 10 mMMgCl2, and
50 mM Tris–HCl, pH 7.8. The cells were homogenized at 0 °C in a
Teﬂon-Glass Potter S homogenizer at 1200 rpm with 10 down-up
cycles. The crude nuclear fraction was obtained by centrifugation of
the homogenate at 1000 ×g for 10 min. The post-nuclear superna-
tant was used for isolation of membrane fractions and cytosol. The
crude nuclear pellet was suspended in the HB buffer and the suspen-
sion was layered onto a ‘sucrose cushion’ consisting of 2 M sucrose.
After centrifugation at 16,000 ×g for 20 min the supernatant was
discarded and the pellet containing puriﬁed nuclei was washed
twice with the HB buffer. The post-nuclear supernatant was centri-
fuged at 200,000 ×g for 40 min. The resulting supernatant was
designated as ‘cytosol’ whereas the pellet was extracted with 0.1 M
Na2C03 and 5 M urea to purify the membrane fractions as described
previously [18].
2.4. Sample preparation
The hepatocytes, hepatocyte subcellular fractions, and cultured
HepG2 cells were lysed in 0.1 M Tris–HCl, pH 7.6, containing 50 mM
DTT and 2% SDS (w/v) in boiling water bath for 4 min. After cooling
to room temperature the lysates were clariﬁed by centrifugation
at 16,000 ×g for 10 min. The lysates were processed according to
the MED-FASP protocol using endoproteinase LysC and trypsin [19].
Total protein and total peptide contents were determined using a
tryptophan-ﬂuorescence assay [20]. Peptides were fractionated using
pipette tip SAX as described previously [21] The LysC-peptides from
whole cell lysates (samples A–G)were fractionated into 4 fractions elut-
ing at pH12, 6, 4, and 2whereas the tryptic peptideswere eluted at pH 5and 2. The LysC and tryptic peptides from subcellular fractions (samples
D and E) were eluted at pH 5 and 2. Except for fractions D and E the
analyses were performed in duplicates. Two samples (F and G) were
also processed by PEGylation strategy into two LysC and two tryptic
fractions of Cys-depleted peptides and one Cys-enriched peptide frac-
tion [22].
2.5. Mass spectrometry and data analysis
Aliquots of peptides were separated on a reverse phase column and
analyzed on a QExactive mass spectrometer (Thermo) as described
previously [7]. Brieﬂy, the peptides were separated on a reverse phase
column (20 cm× 75 μm inner diameter) packed with 1.8 μmC18 parti-
cles (Dr. Maisch GmbH, Ammerbuch-Entringen, Germany) using a 4 h
acetonitrile gradient in 0.1% formic acid at a ﬂow rate of 250 nl/min.
The liquid chromatographywas coupled to a QExactivemass spectrom-
eter (Thermo Fisher Scientiﬁc, Germany) via a nanoelectrospray source
(Proxeon Biosystems, now Thermo Fisher Scientiﬁc). The QExactivewas
operated in data-dependent mode with survey scans acquired at a res-
olution of 50,000 at m/z 400 (transient time 256 ms). Up to the top 10
most abundant isotope patterns with charge ≥ +2 from the survey
scan were selected with an isolation window of 1.6 Th and fragmented
by HCD with normalized collision energies of 25. The maximum ion
injection times for the survey scan and the MS/MS scans were 20 ms
and 60 ms, respectively. The ion target value for both scan modes
were set to 106. The dynamic exclusion was 25 s and 10 ppm.
2.6. Data analysis
The rawdatawere analyzedwithMaxQuant Software (Ver. 1.2.6.20)
using the human UniProt database (Vers. May 2013). The search was
performed with a fragment ion mass tolerance of 0.5 Da and parent
ion tolerance of 20 ppm. The protein and peptide false discovery rates
were set to 1%. Protein abundances were calculated from the spectral
raw intensities using the ‘Total Protein Approach’ [9,23] using the
relationships:
Total protein ið Þ ¼ MS signal ið Þ
Total MS  signal
or
Protein concentration ið Þ
¼ MS signal ið Þ
Total MS signalMW ið Þ
mol
g total protein
 
:
The total protein content of the cells and the protein copy number
per cells was assessed using the ‘Proteomic Ruler’ approach assuming
a DNA content of human cells of 6.5 pg [10] using the relationship:
Total protein=nucleus ¼ 6:5 pg Total MS signal
MS signal Total histoneð Þ pg½ ;
and
Protein copy number ¼ NA  Total protein=nucleus
 Protein concentration;
where NA is the Avogadro number. The calculations were performed in
Microsoft Excel (Supplemental Table 2, sheet ‘Histone ruler’).
2.7. Statistical analysis
Protein concentration and copy number data were processed using
Perseus software 1.5.0.8 (http://www.perseus-framework.org/). For
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tween hepatocytes (7 values) and HepG2 cells (3 values) the minimal
number of values was set to 7 per protein. 6129 proteins passed this
ﬁlter. Imputation of missing values occurred through generation of
random numbers that are drawn from a normal distribution. The
parameters of this distribution can be optimized to simulate a typical
abundance region that the missing values would have if they had been
measured. We used the parameter values of 0.3 for width and 1.8 for
down shift. Typically the missing values simulate low abundance mea-
surements. The t-test signiﬁcances were calculated using the threshold
of 0.05 FDR (Supplemental Table 3).Fig. 1. Quantitative proteomic analysis of the human hepatocyte proteome. (A) Purity of the h
depleted. The titers of the marker proteins in human liver are from [11]. (B) Workﬂow of the
and fractionated into nuclear, membrane and cytosolic fractions before the lysis. The lysat
columns and analyzed by LC–MS/MS. The mass spectra were processed by the MaxQuant so
using the TPA method [23]. (C) Enrichment of marker proteins in the subcellular fractions.
fractions to that in whole cell lysate. ‘Nucleus’, ‘Integral to plasma membrane’, and ‘Cytosol
categories. (D) Subcellular fractionation allows discrimination between proteins associated wi3. Results & discussion
3.1. Experimental design and sample analysis
Hepatocytes isolated from livers of 7 donors were used in this study.
On the basis of the abundance of cell-speciﬁc marker proteins in the
hepatocyte fractions compared to whole liver the hepatocytes were
well depleted from Kupffer and stellate cells and were enriched at
least 10-fold in respect to sinusoidal endothelial cells (Fig. 1A). To obtain
a global picture of the hepatocyte proteome, whole cell lysates were
analyzed. This resulted in an identiﬁcation of 8705 proteins, of whichepatocyte preparations. Proteins speciﬁc for other liver cell types than hepatocytes were
analysis. Hepatocytes were either lysed in SDS-containing buffer or were homogenized
es were processed by MED-FASP and the resulting peptides were fractionated on SAX
ftware and the raw spectral intensities were used for calculation of protein abundances
The enrichment values were calculated as the ratio of the protein concentration in the
’ refer to average values calculated from abundances of all proteins matching these GO
th cell membranes, nuclei and cytosol.
Fig. 2. Comparison of MED FASP and TAPEG FASP for analysis of whole lysates of human hepatocytes. (A) Number of identiﬁed peptides per sample. (B) Protein sequence coverage.
(C) Number of identiﬁed proteins per sample. Run-to run reproducibility using concentrations of proteins identiﬁed with more than 2 peptides: MED-FASP vs. MED-FASP (D), TAPEG
FASP vs. TAPEG FASP (E) and MED-FASP vs. TAPEG-FASP (F).
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Additionally, to provide insights into the subcellular location of proteins
two of the hepatocyte samples were further separated into nuclear,
post-nuclear membrane and cytosolic fractions. (Fig. 1B). These analy-
ses extended the hepatocyte proteome by 337 additional proteins.
Moreover, to increase the depth of proteomic analysis of lysates from
the hepatocyte samples F and G were also processed with TAPEG-
FASP method [22]. In this approach SH-reduced proteins are modiﬁed
with thiol-activated polyethylene glycol (TAPEG) before consecutive
protein digestion with LysC and trypsin and isolation of two fractions
of non-derivatized peptides. After reduction of disulﬁde bonds between
cysteine containing peptides and the polyethylene glycol moieties, a
third fraction of peptides is collected. Comparison of the results showed
that TAPEG-FASP enable identiﬁcation ofmore peptides thanMED-FASP
(Fig. 2A). This results in an average increase of protein sequence cover-
age by 10% (Fig. 2B), but has little effect on the number of identiﬁed
hepatocyte proteins (Fig. 2C). This result resembles the outcome of
the analysis of mouse liver [22]. In terms of run-to run reproducibility
of MED-FASP and TAPEG-FASP were comparable (Fig. 2D-F). Notably,
similar reproducibility was reported for other sample fractionation ap-
proaches [24]. Furthermore, an analysis of 3 samples of HepG2 cells ex-
tended the dataset by 313 proteins, which were speciﬁc to these cells
(Supplemental Table 2).
Comparison of the protein concentrations in the nuclear, membrane
and cytosolic fractions with those in whole lysates allowed for calcula-
tion of enrichment values for each of the subcellular components
(Fig. 1C). Based on the abundances of polypeptides involved in
organization of nuclear pores (NUPs) and the RNA polymerase II, the
enrichment of nuclear proteins was about 17-fold. This value is close
to the theoretically possible enrichment of 14- to 20-fold assuming
that the nuclei constitute 5–7% of the total cell protein. Similarly, high
enrichment values of 13–14-fold were found for the plasmamembrane
proteins organic anion transporting polypeptide (OATP) 2B1 (SLCO2B1)
and theα-subunit of the Na+/K+-pump (ATP1A1) (Fig. 1C). The enrich-
ment of the cytosolic proteins lactate andmalate dehydrogenases in the
cytosolic fraction was about 2-fold, reﬂecting that this fractions consti-
tute about 50% of the cell. The isolation of the subcellular fractions of
the hepatocytes resulted in the identiﬁcation of 1558 cytosolic, 1885membrane, and 2294 nuclear proteins that were enriched at least
2-fold compared to the whole lysate (Fig. 1D).
3.2. Statistical analysis of the differences between the hepatocyte and
HepG2 cell proteomes
At total of 6129 proteins were identiﬁed in at least 7 out of the 10 in
total whole lysate samples of the hepatocytes and HepG2 cells. These
were subjected to calculation of protein ratios and subsequent statistical
analysis. Principal component analysis of the protein concentrations as
well as protein copy numbers revealed a clear separation of the hepato-
cyte and HepG2 samples (Fig. 3A and B). T-test analysis allowed deter-
mination of the statistical signiﬁcance of the protein differences. In total,
concentrations of 4857 proteins and copy numbers of 3936 proteins
were signiﬁcantly (FDR b 0.05) upregulated of downregulated for the
hepatocytes and HepG2 line (Fig. 3C and Supplemental Table 3). 3191
signiﬁcant changes were common to both analyses. 1665 signiﬁcant
changes were unique to the concentration values, whereas 745 were
speciﬁc to copy numbers. This difference clearly shows that proteomic
comparisons of cells that are different in their sizes should be
performed with a particular care. The proportion of proteins organized
in speciﬁc organelles should be considered. Fig. 3D shows that the num-
ber of signiﬁcantly changed proteins in relation to their cellular location
varies between the two different calculation methods. Compared to the
analysis of differences in protein concentrations, the analysis of protein
changes in copy numbers decreases the number of signiﬁcant hits for
nuclear and nucleolar proteins by about 40%. The opposite happens
with the numbers of signiﬁcant changes related to plasma membrane
and mitochondrial proteins, which frequency increases by 10 and 30%
respectively. These differences reﬂect distinct contribution of different
organelles to the total protein of the cell.
The large extent of signiﬁcant differences for the hepatocytes and
HepG2 cells reﬂects both structural and physiological dissimilarities
for these biological systems. Previously we observed a similar degree
of differences between white and red muscle ﬁbers [26] and between
human colon mucosa and its adenoma and cancer [27].
We are also aware that some differences in protein titers could be
related to the various ages of the liver donors.Whereas the hepatocytes
Fig. 3. Statistical analysis. (A) and (B) Principal component analyses of the concentration and copy number values. (C) Overlap between signiﬁcantly changed proteins assessed from
concentration and copy number data. (D) Comparison of the cellular location (GO terms) of the non-overlapping signiﬁcantly changed proteins. The values were calculated using the
formula: {(number of proteins with signiﬁcantly changed concentration / number of proteins with signiﬁcantly changed copy number)−1} × 100%.
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cells originate from a 15 year male. Age related changes in liver include
increases size and ploidy of hepatocytes and altered liver metabolism
and secretion are well documented [28].
3.3. Overview of the human hepatocyte and HepG2 cell proteomes
The human hepatocyte is described by a number of morphometric
and biochemical studies. These analyses provide detailed measures of
the volume, protein content, and subcellular composition as well as
quantitative information on abundance and activity of speciﬁc proteins.
Recently, we have proposed delineation of cell composition by combin-
ing protein abundances measured using the TPA method and cell com-
partment annotations given by ‘Gene Ontology’ [9]. We have shown
that this kind of analysis allows detection of alterations in the architec-
ture of cells undergoing a neoplastic transformation or differentiation
[9] or those exposed to a physiological stress [14]. In addition, this
approach is useful to study protein composition of organelles such as
mitochondria [15]. Applying the ‘Histone ruler’ concept, total protein
contents calculated by TPA can be converted into protein copies per
cell and for organelle-speciﬁc proteins into copies per organelle type.
Using these computational tools,we have calculated the protein content
per single nucleus and the content of the basic subcellular components
of the hepatocyte and the HepG2 cell (Fig. 4A-C). Due to the fact that
about 20% of human hepatocytes are binucleated or polyploid [29],
the copy number values per cell are about 1.2-fold higher compared to
those per nucleus containing 2n DNA. However, these numbers vary
between donors as a result of factors such as age or disease [29,30].
The modal number of chromosomes in the HepG2 cells is 55, while
the corresponding number in somatic human cells is 46. We previously
determined DNA content in the HepG2 cells and found 7.5 pg DNA percell [10]. This is only 15% more compared to the normal somatic cell.
Therefore the copy number values in HepG2 could be up to 15% higher,
resembling the situation in the hepatocytes. For this reason we did not
correct the protein copy numbers.
The ‘Proteomic Ruler’ revealed that human hepatocytes contained
on average 600 pg total protein per cell. In contrast, HepG2 cells were
smaller with on average 170 pg of total protein per cell. Since the total
concentration of proteins in eukaryotic cells lies within a range of 200
to 300 g/l [31], the hepatocyte and HepG2 cell were determined to
have volumes of 3000 μm3 and 850 μm3, respectively (Fig. 4A). The cal-
culated hepatocyte volume is close to a textbook value of 3400 μm3 [1].
Analysis of the subcellular composition of the hepatocyte revealed
that the mitochondria made up about 25% of the total cellular protein
whereas the endoplasmic reticulum (ER) and Golgi apparatus together
constituted 12% of the total protein (Fig. 4B). The nuclei of the hepato-
cytes constituted on average 10% of the total protein. These values are
similar to the data obtained in amorphometric study of themononuclear
rat hepatocytes, estimating the cellular content of nucleus, ER and mito-
chondria to 6, 16, and 23%, respectively [2].
Compared to the hepatocytes, abundances of the organelles in
HepG2 cells were quite different (Fig. 4B). The nuclei of the HepG2
cells constituted as much as 25% of the total cellular protein whereas
mitochondria contained only 12% of the total protein. Because HepG2
cells are about 3 times smaller than the hepatocytes, the sizes of the
nuclei in both cell typeswere similar, containing 7–9 × 108 proteinmol-
ecules (Fig. 4C). Thismay indicate that the apparatus ofmaintaining and
processing genetic information is of a similar size in both cell types. In
contrast, organelles primarily involved in protein synthesis and protein
maturation, i.e., ER and Golgi, as well as energy production, mitochon-
dria, contained on average one order of magnitude more molecules in
human hepatocytes compared to HepG2 cells. Proteins integral to the
Fig. 4. Basic elements of the human hepatocyte proteome. (A) Total protein content and cell volume per nucleus of the hepatocytes and the cultured HepG2 cells calculated using the
‘Proteomic Ruler’ [10]. The cell volume was calculated using the assumption of an average cellular protein concentration of 20%. (B and C) Protein content of selected organelles and
their membrane fractions expressed as fraction of the total protein (B) or cumulative copy number (C). (D and E) Examples of the content of selected cellular assemblages, pathways,
and the most abundant proteins of the hepatocytes. Black and blue dots, show average abundance values calculated for the 7 hepatocyte and 3 HepG2 cell samples, respectively. Gene
names of proteins with statistically signiﬁcant titer-differences between hepatocyte and HepG2 are in red (FDR b 0.05). Arrows indicate statistically signiﬁcant abundance-differences
between HepG2 and hepatocytes at the selected protein groups (P b 0.001). The x-axis label in E shows exponents only.
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cytes (Fig. 4B) whereas HepG2 cells harbored two times more of these
proteins. However,when the abundances of plasmamembraneproteins
were expressed in copies per cell, hepatocytes contained more of these
proteins compared to HepG2 cells (Fig. 4C). This presumably reﬂects a
several-fold larger cell surface of a hepatocyte compared to a HepG2
cell.
The human hepatocyte was found to be composed of on average
8.7 × 109 protein molecules whereas a HepG2 cell only contained
2.5 × 109 (Fig. 4E). Ribosomal proteins of the large and small subunits
constituted each 1.3% of total protein in human hepatocytes and about2.3% in HepG2 cells (Fig. 4D). However, in copy number terms, human
hepatocytes contained on average 2 times more ribosomal proteins
than HepG2 cells (Fig. 4E). The copy numbers for the RNA polymerase
1 and general transcription factors were similar for the hepatocytes
and HepG2 cells whereas RNA polymerases 2 and 3 were 2.6 and 7.2-
fold more abundant in the HepG2 cells (Fig. 4E). Copy numbers of
proteins directly involved in DNA replication, such as the DNApolymer-
ase subunits (POLA-POLE), minichromosome maintenance helicase
complex subunits MCM2-MCM7, replication factor c (RFC1-RCF5), pro-
liferating cell nuclear antigen and (PCNA) and the Ribonuclease H
(RNASEH2C) were 2.5–20 fold higher in the HepG2 cells compared to
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proteins, 15 showed statistically signiﬁcant differences in copy numbers
(Supplemental Table 3). These differences obviously reﬂect lower repli-
cation and cell division rate of the hepatocytes compared to the cultured
cells.
Glycolysis/gluconeogenesis, β-oxidation of fatty acids and oxidative
phosphorylation were the most abundant metabolic pathways in the
hepatocytes. Each involved 1–5 × 108 protein molecules (Fig. 4E) and
constituted 2–3% the total protein (Fig. 4D). Recently, we have reported
similar abundances inmouse liver [15]. For comparison, themajor com-
ponents of the fatty acid synthesis system constituted about 10 times
less total protein in the HepG2 cells and the whole set of proteins in-
volved in drug biotransformation (see below) accounted for 1000,000
molecules in the human hepatocyte but only 100,000 molecules in the
HepG2 cell.
Next, we compared the abundances of single proteins (Fig. 4D and
E). In the hepatocytes, fatty acid binding protein (all isoforms together)
was the most abundant in respect to its number of copies while
carbamoyl phosphate synthase (CPS) was the most abundant by mass
(4–6% of total mass) (Fig. 4D). Considering that mitochondria occupy
25% of the hepatocyte, CPS constituted 20% of total mitochondrial pro-
tein. We have recently reported a comparable value for mouse liver
[15]. Serum albumin, being synthesized by hepatocytes, was another
highly abundant protein. It constituted on average 2 × 107 copies per
cell which accounted for 0.3% of the total protein of the hepatocyte. In
the HepG2 cells, the titers of albumin and CPS were about one order of
magnitude lower than in the hepatocytes. The differences between
the HepG2 cell line and native hepatocytes were not only restricted to
titers of proteins but also manifested itself in changes from one isoform
to another. For example, aldolase B was the key enzyme in hepatocytes
whereas the dominant isoform in the HepG2 cells was aldolase A, which
is most common in normal muscle tissue (Fig. 4D and E).
3.4. Protein synthesis
Hepatocytes are responsible for synthesis of many extracellular
proteins. The most prominent are serum albumin, clotting factors, and
α- and β-globulins. These proteins play vital roles in the organism and
can often be used as markers for liver diseases. Protein synthesis starts
with ligation of amino acids to their speciﬁc transfer RNAs (tRNAs)
and often ends with attachment of sugar moieties (Fig. 4).
Ligation of the amino acids to their respective tRNA is the ﬁrst step
in the assembly of proteins. We found a correlation between the con-
centrations of the amino acid tRNA synthases and the frequency of the
amino acids in the hepatocyte proteome (Fig. 5A). The Cys-tRNA and
Trp-tRNA synthases showed the lowest concentrations of about
1 pmol/mg, which reﬂects the lowest frequency of cysteine and trypto-
phan in the hepatocyte proteome. In contrast, the summed abundance
of Leu-tRNA and Ile-tRNA synthases was high (about 5 pmol/mg) and
related to the highest frequency of these amino acids. In respect to the
amino acid frequency, tRNA synthases of aspartic acid and tyrosine
appeared to be more abundant compared to other tRNA synthases. In
the HepG2 cells, the titers of the amino acid tRNA synthases were on
average 2-fold higher than in the hepatocytes. This obviously reﬂects
higher titers of the RNA polymerase 2 in HepG2 cells compared to the
hepatocytes (Fig. 4D). Notably, titers of the major factors involved in
elongation were also about two times more abundant in the HepG2
cells than in the hepatocytes (Fig. 5B). The higher abundances likely
reﬂect differences in cell division. The HepG2 population doubles
about every 24 h, while primary hepatocytes of adult livers divide
only rarely.
Protein glycosylation is a common posttranslational modiﬁcation
of the extracellular proteins. Generally, this modiﬁcation falls into one
of two classes, the N-type at the asparagine residues and the O-type at
serine residues [32,33]. Both types of glycosylation involve complex
machineries synthesizing and attaching glycan moieties to proteins. Inthe case of the N-glycosylation a series of reactions leads to the forma-
tion of a glycan precursor, the dolichol-P–P-GlcNAc2Man9Glc3 and its
attachment to asparagine residues by the oligosaccharyltransferase
complex (OST) [33]. Both the dolichol-P–P-GlcNAc2Man9Glc3 and
the OST complex had higher titers in the hepG2 cells compared to
the hepatocytes (Fig. 5C). In contrast, titers of enzymes involved in
O-glycosylation varied for the two types of cells (Fig. 5D). Whereas
titers of sialylating and fucosylating transferases were higher in hepato-
cytes than in HepG2 cells, titers of transferases of UDP-glucose and
xylose and UDP-N-acetylglucosamine were higher in HepG2 cells. The
deﬁciency in salylated glycans is common to cultured cell lines [34].
The liver is the main source of plasma proteins. In Fig. 5E we com-
pared the cellular concentration of several prominent plasma proteins
with their concentrations in plasma [15]. We observed that the concen-
trations of plasma proteins in the hepatocytes were similar or higher
compared to their titers in plasma. In HepG2 cells, titers of serum
albumin, transferrin and SERPINA1 were similar to those in human
hepatocytes, whereas other proteins, including ceruloplasmin (CP),
were down-regulated. Hemopexin (HPX), which transports heme into
the liver for breakdown and iron recovery, was not detected in the
HepG2 cells.
3.5. Energy metabolism
Energy metabolism consists of diverse cellular processes dedicated
to energy supply and storage. The major pathways involved in these
processes are shown in Fig. 6.
Glucose, after phosphorylation by hexokinase or glucokinase to G6P,
can be directly used for production of ATP through glycolysis, converted
into glycogen, or can enter the pentose phosphate pathway allowing the
redirection of metabolic ﬂuxes to meet a variety of physiological re-
quirements (Fig. 6A–C). The latter pathway plays a key role in providing
NADPH for lipid synthesis and pentose precursors for synthesis of
nucleic acids. Furthermore, via the gluconeogenic process, which also
involves some glycolytic enzymes, G6P can be produced from pyruvate.
We observed clear differences between hepatocytes and HepG2 cells
with regards to energy metabolism pathways. For example, 1,6-glucose
bisphosphatase (FBP1), the key enzyme of the gluconeogenesis, was 3
orders of magnitude less abundant in HepG2 cells than in hepatocytes
(Fig. 6A). Notably, this enzyme was the most abundant of the key
metabolic enzymes in hepatocytes with titers of over 100 pmol/mg
(Fig. 6A). The high abundance of FPB together with high titers of lactate
dehydrogenase points at the role of liver in the Cori cycle in which the
hepatocytes convert lactate released from muscles to glucose.
Glycogen is the key energy storage depot in hepatocytes. The titers
of enzymes involved in the synthesis and degradation of glycogen
were 1–2 orders of magnitude higher in the hepatocytes compared
to the HepG2 cells (Fig. 6B), indicating that in the latter the glycogen
metabolism is negligible.
Pyruvate, the ﬁnal product of the glycolysis, undergoes decarboxyl-
ation to acetyl-CoA by pyruvate dehydrogenase. This enzyme is com-
posed of multiple copies of three major subunits: PDH (including
isoforms A, B and X), DLAT, and DLD (Fig. 6D). The concentrations
of these proteins in the hepatocytes and the HepG2 cells were within
1-10 pmol/mg. Similar concentrations of the pyruvate dehydrogenase
components are found in whole mouse liver lysates [15]. Acetyl-CoA
may be used in the Krebs cycle to produce energy equivalents, NADH.
Similarly to the enzymes involved in the glycolysis, the titers of many
Krebs cycle enzymes varied between the hepatocytes and the HepG2
cells. For example, in HepG2 the concentration of citrate synthase was
5 times higher than in the hepatocytes (Fig. 6E).
Moreover, the abundances of the iso-citrate dehydrogenases 2 and 3
showed clear differences between the native and cultured cells. In the
hepatocytes, the dehydrogenation of iso-citrate appeared to be carried
out mainly by IDH2which releases NADPH, whereas IDH3 (3 subunits),
producing NADH, was the more abundant enzyme in the cultured
Fig. 5. Concentrations of enzymes involved in various steps of protein synthesis andmaturation. (A) Abundance of the amino acid t-RNA ligases as a function of the amino acid frequency
observed in the hepatocyte proteome. (B) Concentrations of key proteins involved in polypeptide elongation during translation. (C) Synthesis of dolichol-P-P-GlcNAc2Man9Glc3 for
N-glycan synthesis and N-glycan transferases, and (D) O-glycan transferases. (E) Correlation of the abundances of plasma proteins synthesized in hepatocytes and their titers in
plasma. Black and blue dots, show average abundance values calculated for the 7 hepatocyte and 3 HepG2 cell samples, respectively. Gene names of proteins ns with statistically
signiﬁcant titer-differences between hepatocyte and HepG2 are in red (FDR b 0.05). Arrows indicate statistically signiﬁcant abundance-differences of the selected protein
groups (P b 0.001). All amino acid t-RNA ligases showed (A) statistically signiﬁcant titer-differences (Supplemental Table 3).
241J.R. Wiśniewski et al. / Journal of Proteomics 136 (2016) 234–247HepG2 cells. Thismay be accompaniedwith higher needs for NADPH by
themitochondrial cholesterol side chain cleavage system in the hepato-
cyte mitochondria.
Because NADH produced in the cytoplasm is unable to pass the
mitochondrial membranes, it is used by the malate/aspartate shuttle
mechanism to regenerate mitochondrial NAD (Fig. 6G). The shuttle
involves malate dehydrogenases (MDH1 and MDH2) and aspartateaminotransferases (GOT1 and GOT2) with speciﬁc cytoplasmic and
mitochondrial locations. Both the cytoplasmic and the mitochondrial
enzymes were highly abundant. Another mechanism, known as the
glycerol-3-phosphate shuttle, allows regeneration of mitochondrial
NAD to NADH using glycerol-3-phosphate, a by-product of glycolysis
(Fig. 6F). The mechanism involves cytoplasmic (GPD1) and mitochon-
drial glycerol-3-phosphate dehydrogenase (GPD2). The concentrations
Fig. 6. Energy metabolism. (A) Glycolysis and gluconeogenesis. (B) Pentose phosphate pathway. (C) Glycogen metabolism. (D) Pyruvate dehydrogenase complex. (E) Krebs cycle,
(F) Glycerol-3-phosphate shuttle. (G) Malate/aspartate shuttle. (H) Ligation of fatty acids to CoA for lipid synthesis and β-oxidation. (I) Microsomal oxidation of fatty acids. (J) Carnitine/
acyl carnitine shuttle (K) Mitochondrial oxidation of fatty acids. (A–K) Protein abundances are expressed in pmol/mg total protein. (L) Summed abundances (total protein) of the
complexes involved in oxidative phosphorylation. Black and blue dots, show average abundance values calculated for the 7 hepatocyte and 3 HepG2 cell samples, respectively. Gene
names of proteins ns with statistically signiﬁcant titer-differences between hepatocyte and HepG2 are in red (FDR b 0.05). Arrows in M indicate statistically signiﬁcant abundance-
differences of the selected protein groups (P b 0.001).
242 J.R. Wiśniewski et al. / Journal of Proteomics 136 (2016) 234–247of these enzymes were lower compared to the enzymes of the malate/
aspartate shuttle. This obviously reﬂects a secondary role of the
glycerol-3-phosphate shuttle in the regeneration ofmitochondrial NAD.Ligation to CoA initiates cellular metabolism of free fatty acids. This
process is carried out by several ligases. In hepatocytes long-chain-
fatty-acid-CoA ligase 1 (ACSL1) is the most abundant one, whereas in
243J.R. Wiśniewski et al. / Journal of Proteomics 136 (2016) 234–247HepG2 cells isoform 2 (ACSL2) and 3 (ACSL3) play the major role
(Fig. 6H). In the next step, the CoA-ligated fatty acids can be incorporat-
ed intomono-, di- and triglycerides or can be degraded in the process of
β-oxidation, which produces Ac-CoA, NADH and FADH2. Palmitic-CoA
and shorter aliphatic acid-CoAs are transported into mitochondria by
the carnitine/acylacarnitine shuttle for β-oxidation (Fig. 6J and K).
Fatty acids with chains longer than 16 carbons are preferentially
oxidized in peroxisomes (Fig. 6I). Considering the abundances of key
enzymes of β-oxidation, mitochondrial fatty acid oxidation prevails
over the same process in peroxisomes. For example, based on the
abundances of the last enzyme in the cycle, thiolase (ACAA1, ACCA2),
mitochondria have 5- to 10-fold higher capacity for fatty acid oxidation
than peroxisomes. Finally, hepatocytes have about one order of magni-
tude higher potential to generate energy from fatty acids compared to
HepG2 cells.
Beside glycolysis, oxidative phosphorylation is the only cellular
process generating ATP in animal cells. For both hepatocytes and
HepG2 cells, the sum of all proteins involved in oxidative phosphoryla-
tion constituted about 3% of total cellular protein (Fig. 6D). Although the
abundances of four complexes of the oxidative phosphorylation cascade
were similar for hepatocytes and HepG2 cells, complex II was signiﬁ-
cantly less abundant in HepG2 cells (Fig. 6L). This may indicate less
ATP production via oxidative phosphorylation in the cultured cells
and together with the higher titers of hexokinase and the high afﬁnity
glucose transporter Glut1 (SLC2A1)(Fig. 7) may reﬂect the Warburg
effect, which is common to cancer cells [35].
3.6. Metabolite transport across plasma membranes
The nutrients and metabolites have to be transferred across cellular
membranes by speciﬁc transport mechanisms [36]. Our previous work
has demonstrated that these membrane proteins can be quantiﬁed
by our proteomic platform. The present hepatocyte proteome dataset
covered about 200 transport proteins, of which 80% belonged to the
solute carrier (SLC) gene families (Supplemental Table 2). In Fig. 7, a
selection of the most prominent transporters of the plasma membrane
and mitochondrial outer and inner membranes is shown.
In the plasmamembrane of human hepatocytes, the most abundant
carrier proteins were the Na+/K+ ATPase (ATP1B), the passive glucose
transporter 2 (GLUT2, SLC2A2) and the fatty acid transport protein
2 (FATP2, SLC27A2) (Fig. 7A, B, C). They occurred at concentrations of
10 pmol/mg total protein which correspond to on average 2–5 × 106
copies per cell (Fig. 7E). The plasma membrane also harbors a large
number of amino acid transporters, which can be ordered in speciﬁc
classes according their transport mechanism (Fig. 7D). The cumulative
abundance of amino acid transporters in human hepatocyte was on
average 1 × 106 copies per cell.
Compared to hepatocytes, the HepG2 cells displayed a quite differ-
ent composition of transporters in the plasma membrane. The cellular
concentrations of theNa+/K+-pumpand the sarcoplasmic/endoplasmic
reticulum calcium ATPase 1 (ATP2A1) were 3- and 10-fold higher
in HepG2 cells compared to the hepatocytes (Fig. 7A). In HepG2
cells, GLUT2 was replaced by GLUT1 (SLC2A1) and GLUT3 (SLC2A3)
(Fig. 7B). The amino acid transporting systems in the HepG2 cells was
differently organized than in the hepatocytes (Fig. 7D). In addition, the
cumulative number of the amino acid transporters per cell was higher
in HepG2 cells than in hepatocytes (Fig. 7E).
The observed differences of plasma membrane transporters be-
tween hepatocytes and HepG2 cells reﬂect differences in cell metabo-
lism. Whereas β-oxidation of fatty acids dominates in hepatocytes,
HepG2 cells preferentially metabolize glucose and amino acids.
3.7. Mitochondrial transport
Generally mitochondria are composed of two layers of membranes,
the outer and the inner one. Since membranes are impermeable tometabolites, the latter are transported across the membranes by
pumps and shuttle mechanisms. To obtain precise insights into the
organization of mitochondrial transport we expressed concentrations
per mitochondrial fraction (Fig. 7F–L) and protein copy numbers of
mitochondrial transporters per single mitochondrion (Fig. 7M). To
calculate the mitochondrial concentrations we used the values of total
mitochondrial protein contents of 25% and 12% in hepatocytes and
HepG2 cells, respectively (Fig. 2B). For calculation of the protein copies
permitochondrionwe assumed 2000mitochondria per hepatocyte [37]
and 250 mitochondria per HepG2 cell. The latter value is an average
number of mitochondria observed in cultured cells [38].
The metabolite transport via the outer mitochondrial membrane is
regulated by voltage-dependent anion channel (VDAC) proteins that
are also known as porins. In hepatocytes and HepG2 cells we identiﬁed
three isoforms of VDACs (Fig. 7F). VDAC1 was the most abundant in
both cell types. However, the concentration of VDAC1 in the hepatocyte
mitochondria was about one order of magnitude lower than in the
mitochondria of HepG2. Similar differences were also observed for the
VDAC2 and VDAC3 isoforms. Thus, our data most probably indicate
large differences in the organization of the outer mitochondrial mem-
brane. On the other hand, the higher abundance of the VDACs in
HepG2 can also be partially attributed to the occurrence of porins in
plasma membranes [39].
The innermitochondrialmembrane harbors a large number of trans-
port proteins. The most abundant ones were the ADP/ATP translocases
(SLC25A4, 5 and 6) and the phosphate pump (SLC25A3), which are the
key components of the ATP synthase machinery (Fig. 7G). Transporters
involved in metabolite shuttling constitute the next group of abundant
proteins located in the inner membrane (Fig. 7H, I, J, K, and L). In con-
trast to porins, the concentrations of many of these transporters were
comparable in hepatocytes and HepG2 cells with some exceptions. For
example, the citrate/malate and dicarboxylate transporters (Fig. 7H)
weremore abundant in HepG2 cells than hepatocytes. These differences
correlatewell with higher citrate synthase titers inHepG2 cells (Fig. 6E).
Moreover, the acylcarnitine/carnitine transporter (Fig. 7K) occurred at
signiﬁcantly higher concentration in hepatocytes compared to HepG2
cells reﬂecting high fatty acid catabolism in hepatocytes (Fig. 6J and K).
Finally, expressing the protein abundances in copy numbers, we
calculated that a single mitochondrion in the hepatocyte contains
5000–10,000 porins and ATP translocases (Fig. 6M). The pyruvate and
the carnitine transporters were 2–3 times less abundant than the porins
and ATP translocases. The ornithine transporter occurred in 1000 copies
on average, whereas transport of CoA is carried out by only 100–500
molecules. The mitochondria of HepG2 cells differed from that of hepa-
tocytes by higher abundances of the porins and lower copy numbers for
ornithine, carnitine, and CoA transporters.
3.8. Uptake, metabolism, and efﬂux of drugs
Hepatocytes play an important role in the elimination of drugs
and other xenobiotic compounds from the blood circulation. The
hepatobiliary elimination consists of the following phases: basolateral
uptake (Fig. 8A), phase I and phase II metabolism (Fig. 8B and C), and
biliary/sinusoidal efﬂux (Fig. 8D). In general, membrane transport pro-
teins of the solute carrier (SLC) family facilitate the hepatic uptake of
drugs, while excretion into the bile and blood is carried out by trans-
porters of the ATP-binding cassette (ABC) family. By determining the
amount of drug that enters and exits the cell, the transport proteins
may also inﬂuence the rate and extent of drug metabolism.
Analysis of the whole cell lysates revealed that the most abundant
uptake transporters in the basolateral membrane of the hepatocytes
were organic anion transporting polypeptide 1B1 (OATP1B1, SLCO1B1),
OATP1B3 (SLCO1B3), and organic cation transporter 1 (OCT1, SLC22A1).
They occurred at concentrations of around 1 pmol/mg total protein
which corresponds to on average 4–7 × 105 copies per cell. The
sodium-taurocholate transporting polypeptide (NTCP, SLC10A1), which
Fig. 7. Abundances of nutrient andmetabolite transport across the plasma (A–E) andmitochondrial membranes (F–J). (A–D) Concentrations of plasmamembrane transporters for cations
(A); glucose and lactate (B); fatty acids (C), and amino acids. In D, the amino acid speciﬁcity of some transporters is indicated using the single amino acid code. (E) Protein copy numbers of
selected transporters. Concentrations of porin subunits in the outermitochondrialmembrane (F) and transporters in the innermitochondrial membrane (G-L). (M) Protein copy numbers
per mitochondrion of selected transporters. The values were calculated under the assumption of 2000 mitochondria per hepatocyte and 250 mitochondria per HepG2 cell, respectively.
Black and blue dots, show average abundance values calculated for the 7 hepatocyte and 3 HepG2 cell samples, respectively. Gene names of proteins ns with statistically signiﬁcant
titer-differences between hepatocyte and HepG2 are in red (FDR b 0.05). Arrows indicate statistically signiﬁcant abundance-differences of the selected protein groups (P b 0.001).
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Fig. 8. Abundances of key proteins for drug transport and metabolism. (A) Uptake transporters in the basolateral membrane. (B) Enzymes of drug oxidation (phase I metabolism).
(C) Enzymes of phase II drug metabolism. (D) Efﬂux transporters in the canalicular and basolateral membrane. Black and blue dots show average abundance values calculated for the
7 hepatocyte and 3 HepG2 cell samples, respectively. Gene names of proteins with statistically signiﬁcant titer-differences for hepatocytes and HepG2 cells are in red (FDR b 0.05).
245J.R. Wiśniewski et al. / Journal of Proteomics 136 (2016) 234–247is the major hepatic uptake transporter of bile acids from the blood, was
about one order of magnitude less abundant. In contrast to hepatocytes,
the HepG2 cells failed to display OATP1B1, OATP1B3, OCT1, and NTCP in
quantiﬁable levels.
Phase I metabolizing enzymes introduce reactive or polar groups
into their substrates and were expressed in the hepatocytes in levels
comparable to those reported for human liver tissue [13,40]. In the
HepG2 cells, these enzymes were either absent or expressed in very
low amounts (Fig. 8B). This included the important CYP3A4 enzyme,
which was 100- to 400-fold more abundant in the hepatocytes than in
the HepG2 cells. Other signiﬁcant drug-metabolizing CYP enzymes,such as CYP1A2, CYP2B6, CYP2C9, CYP2C19, and CYP2D6, displayed
concentrations of 3–28 pmol/mg total protein on average in the hepato-
cytes, whereas the levels were not quantiﬁable in the HepG2 cells.
Interestingly, the related cell line HepaRG expresses some of these en-
zymes [41]. Their protein concentrations in HepaRG cells are, however,
unknown.
Contrary to the phase I enzymes, the phase II enzymes, which form
conjugates with charged molecules such as sulfate, glucuronic acid
and glutathione, differed to a variable extent between the hepatocytes
and the HepG2 cells. While SULT1A1, SULT2A1 were expressed at al-
most similar titers in the hepatocytes and HepG2 cells, the expression
246 J.R. Wiśniewski et al. / Journal of Proteomics 136 (2016) 234–247of other phase II enzymes, including UGT1A1, UGT1A4, UGT1A6,
UGT2B7, UGT2B15, and GSTM1, was not present or very low in the
HepG2 cells compared to the hepatocytes.
Conjugates from phase II metabolism are excreted into the bile and/
or the blood by efﬂux transporters in the canalicular and basolateral
membrane of the hepatocytes, respectively. This process is sometimes
referred to as phase III metabolism. The most abundant efﬂux trans-
porter in the canalicular membrane of the hepatocytes was the bile
salt export pump (BSEP, ABCB11) at 1.4 pmol/mg total protein, followed
bymultidrug resistance-associated protein 2 (MRP2, ABCC2) andmulti-
drug resistance protein 1 (MDR1, ABCB1). Most of the canalicular efﬂux
transporters were present in the HepG2 cells at levels close to those
found in hepatocytes. BSEP titers were, however, 100-fold lower in the
HepG2 cells than in the hepatocytes. These ﬁndings are supported by
studies on mRNA level [42,43]. The titers of the basolateral efﬂux trans-
porters MRP3 and MRP6 were 4- to 20-fold lower in the HepG2 cells
than in hepatocytes, whereasMRP4 was not present in the HepG2 cells.
In summary, the shortage of uptake transporters and phase I
enzymes clearly limits the use of HepG2 cells for the prediction of xeno-
biotic metabolism and elimination. Our ﬁndings are in agreement with
previous studies at the mRNA [43–45] and protein levels [13,40].4. Conclusions
Technological progress in proteomics offers quantitative analysis of
tissues and cells encompassing the entire proteome. Notably, it is now
possible to do such analyses without laborious preparation of standards
or generation of calibration curves. Protein titers and copy numbers can
be assessed directly from proteomic data using the TPA and ‘Proteomic
Ruler’ methods. We applied these computational advancements to
study the human hepatocyte proteome. We draw a virtual picture of
this cell providing information of its size, subcellular composition
and abundance of speciﬁc proteins, protein complexes, and pathways.
Notably, we provide the ﬁrst in-depth comparative and quantitative
proteomic analysis of human adult hepatocytes and HepG2 cells. The
dataset can be used to match the titer data with biochemically assessed
enzyme and/or transporter kinetic parameters for systems biology
modeling approaches [11,25].
Our data delineate extensive differences between human hepato-
cytes and cultured HepG2 cells. These are in line with previously
published results comparing relative protein levels of 432 proteins
between cultured human adult hepatocytes and the HepG2 cells [46].
In contrast to that work our data quantitatively describe protein titers
and demonstrate alterations between the freshly isolated hepatocytes
and cultured cells. The huge differences in the titers of drug uptake
and excretion transporters and Phase I and II metabolism enzymes
questions the value of HepG2 cells as an in vitro model for pharmaco-
and toxicokinetic studies.
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